EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN

Julia Roquigny, Marie-Sophie Meuleman, Carine El Sissy, Paula Vieira Martins, Seppo Meri, Anna Duval, Moglie Le Quintrec, Fadi Fakhouri, Sophie Chauvet, Véronique Frémeaux-Bacchi

Nephrology Dialysis Transplantation · 30.05.2025 · 40 (6) · 1081-1090

DOI: 10.1093/ndt/gfae243 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 13.11.2024. Verfasst von Julia Roquigny und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranoproliferative, Complement C3-C5 Convertases, Complement C3. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, European Union's Horizon 2020 Marie Skłodowska-Curie project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulation of the alternative pathway of complement plays a central role in the pathophysiology of C3 glomerulopathy (C3G). Various autoimmune and genetic factors targeting the alternative pathway have been associated with both C3G and primary immunoglobulin-associated membranoproliferative glomerulonephritis (Ig-MPGN), suggesting shared pathophysiological mechanisms. This review highlights the wide range of disease drivers identified that mainly target components or protein complexes of the alternative pathway, both in C3G and Ig-MPGN. Nephritic factors, which constitute a heterogeneous group of autoantibodies targeting the C3 or the C5 convertase, are the most common abnormalities. Monoclonal gammopathies are frequent in aging adults. They may promote complement activation and have in some cases also been found to target alternative pathway regulatory proteins. Additionally, some patients with C3G and Ig-MPGN carry rare variants in genes encoding complement activating or regulating proteins of the alternative pathway. This review provides an informative overview of pathogenetic mechanisms associated with each abnormality, acting at different steps in the complement cascade. The diversity of targets involved in the C3G pathophysiology suggests the potential benefit of therapeutical approaches tailored to the underlying disease drivers, with a pivotal impact upstream or at the level of the C3 or C5 convertase activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranoproliferativeComplement C3-C5 ConvertasesComplement C3HumansComplement Pathway, Alternative

Stichwörter der Autor:innen

C3 glomerulopathyalternative pathwaycomplement systemconvertasemembranoproliferative glomerulonephritis

Substanzen

Complement C3-C5 ConvertasesComplement C3

Autor:innen und Institutionen

  • Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France.
  • Department of Bacteriology and Immunology, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Department of Immunology, Assistance Publique-Hôpitaux de Paris (AP-HP), Georges Pompidou European Hospital, Paris, France.
  • Department of Nephrology, Strasbourg University Hospital, Strasbourg, France.
  • Department of Nephrology, Université de Montpellier, CHU de Montpellier, Montpellier, France.
  • Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Förderung

  • Agence Nationale de la Recherche
  • European Union's Horizon 2020 Marie Skłodowska-Curie project

Zitieren

APA

Roquigny, J., Meuleman, M. S., El Sissy, C., Martins, P. V., Meri, S., Duval, A., Le Quintrec, M., Fakhouri, F., Chauvet, S., & Frémeaux-Bacchi, V. (2025). Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN. Nephrology Dialysis Transplantation, 40(6), 1081-1090. https://doi.org/10.1093/ndt/gfae243

Vancouver

Roquigny J, Meuleman MS, El Sissy C, Martins PV, Meri S, Duval A, et al. Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN. Nephrology Dialysis Transplantation. 2025;40(6):1081-1090. doi:10.1093/ndt/gfae243

BibTeX
@article{Roquigny2025,
  author = {Roquigny, Julia and Meuleman, Marie-Sophie and El Sissy, Carine and Martins, Paula Vieira and Meri, Seppo and Duval, Anna and Le Quintrec, Moglie and Fakhouri, Fadi and Chauvet, Sophie and Frémeaux-Bacchi, Véronique},
  title = {Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN},
  journal = {Nephrology Dialysis Transplantation},
  year = {2025},
  volume = {40},
  number = {6},
  pages = {1081--1090},
  doi = {10.1093/ndt/gfae243}
}
Kostenlos starten →